AutoICD API

R89.8

Billable

Oth abnormal findings in specimens from oth org/tiss

Other abnormal findings in specimens from other organs, systems and tissues

Status

Billable / Specific

Block

R83-R89

Parent Code

R89

ICD-11 Mapping

1 equivalent

Coding Notes

Inclusion Terms

Alternative clinical terms for this condition

  • Abnormal chromosomal findings in specimens from other organs, systems and tissues

Includes

Conditions included under this code

  • abnormal findings in nipple discharge
  • abnormal findings in synovial fluid
  • abnormal findings in wound secretions

Excludes 1

Codes that cannot be used together with this code (mutual exclusion)

Related Codes(9)
ICD-11 Equivalents(1)
Also Known As / Clinical Terms(1384)

SNOMED CT

Clinical Terms

  • Bone marrow erythropoiesis hyperplasia
  • Galactose below reference range
  • Molecular dissociation
  • Increase of specific gravity
  • Influenza A virus subtype H1 detected
  • Constitutional mismatch repair deficiency syndrome due to PMS1 homolog 2, mismatch repair system component mutation
  • CYP2C9 *3/*3 poor metabolizer
  • Hardening
  • Calculus chemical composition - finding
  • Acellular smear
  • Abnormally hard consistency
  • Autosomal dominant combined variable immunodeficiency due to NFKB1 deficiency
  • CYP2C9 ultra-rapid metaboliser
  • Increased glucose level
  • Cytochrome P450 family 1 subfamily A member 2 poor metabolizer
  • Calculus = bilirubin
  • Deoxyribonucleic acid damage
  • Macromolecular defective synthesis
  • DNA damage
  • Synovial fluid viscosity - finding
  • Laxness
  • Intron 22 inversion
  • Finding by inspection (simple observation)
  • Uroporphyrin below reference range
  • Cytochrome P450 family 2 subfamily C member 9 *3/*3 poor metaboliser
  • Genetic mutation
  • ABCG2 poor function
  • Presence of crystals
  • Constitutional mismatch repair deficiency syndrome due to PMS2 mutation
  • Protein conformation
  • Abnormal presence of glucose
  • Abnormally increased laxity
  • VKORC1 (vitamin K epoxide reductase complex 1) poor metaboliser
  • Malignant hyperthermia predisposition due to CACNA1S (calcium voltage-gated channel subunit alpha1 S) gene mutation positive
  • CYP3A4 (cytochrome P450 family 3 subfamily A member 4) poor metabolizer
  • Autosomal recessive common variable immunodeficiency due to membrane spanning 4-domains A1 mutation
  • Abnormal organ weight
  • Increased macromolecular binding
  • Arylamine N-acetyltransferase 2 slow acetylator
  • Vitamin K epoxide reductase complex 1 ultra-rapid metabolizer
  • Decreased orotic acid
  • Genetic linkage disequilibrium
  • Abnormal size
  • Tyrosine below reference range
  • HER2 (human epidermal growth factor receptor 2) gene amplification detected
  • Autosomal dominant combined immunodeficiency due to STAT5b deficiency
  • Autosomal recessive combined immunodeficiency due to MAN2B2 mutation
  • Needle shaped crystals present
  • CYP4F2 (cytochrome P450 family 4 subfamily F member 2) poor metaboliser
  • Specimen grossly icteric
  • Protein electrophoresis abnormal
  • Specific gravity above reference range
  • Joint fluid turbid
  • Synovial fluid: crystals
  • Autosomal dominant combined variable immunodeficiency due to SEC61A1 mutation
  • Finding of vitamin B12 level
  • GU test observation
  • Nucleic acid conformation
  • Genetic susceptibility to cancer
  • Carbohydrate conformation
  • Increased translucency
  • CYP2C9 *2/*3 poor metaboliser
  • B-Raf serine/threonine kinase gene mutation detected
  • Cancer antigen 27-29 above reference range
  • Genetic mosaic
  • Inv1 - intron 1 inversion
  • Mannoheptulose above reference range
  • Urobilin below reference range
  • Autosomal recessive common variable immunodeficiency due to complement C3d receptor 2 mutation
  • Autosomal recessive combined variable immunodeficiency due to ARHGEF1 deficiency
  • VKORC1 ultra-rapid metabolizer
  • Finding of specific gravity
  • Decreased galactose
  • Abnormal chromosomal findings in specimens from other organs, systems and tissues
  • Human papillomavirus deoxyribonucleic acid detected
  • Abnormal nucleic acid sequence
  • Cytochrome P450 family 2 subfamily C member 9 *6/*8 poor metaboliser
  • CYP2C9 (cytochrome P450 family 2 subfamily C member 9) ultra-rapid metabolizer
  • Increased glycogen
  • CYP3A5 (cytochrome P450 family 3 subfamily A member 5) ultra-rapid metaboliser
  • CYP1A2 poor metabolizer
  • Increased methemalbumin
  • Specimen slightly icteric
  • ABCG2 decreased function
  • Autosomal recessive combined variable immunodeficiency due to BAFF-R mutation
  • Joint fluid yellow
  • Presence of ova cysts and parasites
  • Tumor protein p53 detected
  • Molecular inactivation
  • Synovial fluid: abnormal content
  • Specimen hemolyzed
  • Amino acid below reference range
  • Monocyte count - finding
  • CYP2C9 ultra-rapid metabolizer
  • Decreased methemalbumin
  • Cytochrome P450 family 3 subfamily A member 5 ultra-rapid metaboliser
  • Decreased porphyrin
  • Abnormal presence of hemoglobin
  • Methaemalbumin below reference range
  • Amniotic fluid alpha-fetoprotein abnormal
  • Carbohydrate above reference range
  • Pentose above reference range
  • CYP2C9 *6/*11 poor metabolizer
  • CYP3A4 (cytochrome P450 family 3 subfamily A member 4) poor metaboliser
  • Autosomal dominant combined variable immunodeficiency due to TWEAK mutation
  • Cytochrome P450 family 1 subfamily A member 2 rapid metabolizer
  • Histidine below reference range
  • BRAF serine threonine kinase gene mutation positive
  • Amniotic fluid AFP - finding
  • Cytochrome P450 family 4 subfamily F member 2 poor metaboliser
  • Ascorbic acid below reference range
  • Increased xanthine
  • Vitamin B below reference range
  • SCBMS (seizures, cortical blindness, microcephaly syndrome) with combined immunodeficiency due to DIAPH1 mutation
  • Cell division alteration
  • Vitamin D above reference range
  • Increased fructose
  • CYP3A5 ultra-rapid metaboliser
  • Increased laxity
  • Adenylic acid below reference range
  • Genetic finding detected
  • CYP1A2 (cytochrome P450 family 1 subfamily A member 2) poor metaboliser
  • Combined immunodeficiency due to IKAROS family zinc finger 2 mutation
  • Bone marrow megaloblastic
  • Mitotic arrest
  • Biliverdin above reference range
  • Heterozygous NFKBIA gene mutation detected
  • Combined immunodeficiency due to HELIOS deficiency
  • Calculus = hydroxyapatite
  • Decreased amino acid
  • Increased lactic acid level
  • CYP2C9 *3/*3 poor metaboliser
  • Increased galactose
  • Breast cancer genetic marker of susceptibility detected
  • Abnormal presence of protein
  • CYP3A4 rapid metaboliser
  • Abnormal nucleotide base sequence
  • Decreased ceroid
  • Finding of quantity of amniotic fluid
  • Mucopurulent
  • Specimen grossly lipaemic
  • Trisomy 18 detected by multiple marker screening
  • Abnormal macromolecular binding
  • Suture material present
  • Observation of quantity of liquor
  • Increased ketone bodies
  • CYP2C9 poor metabolizer
  • Heterozygous protocadherin 19 gene mutation detected
  • VKORC1 (vitamin K epoxide reductase complex 1) rapid metabolizer
  • NAT 2 (N-acetyltransferase 2) poor metabolizer
  • Alteration of genetic material
  • Autosomal recessive CVID (combined variable immunodeficiency) due to TNFRSF13C mutation
  • Autosomal recessive combined variable immunodeficiency due to PIK3CG mutation
  • Abnormally increased organ weight
  • Missense
  • Snowstorm knee
  • Small insertion
  • Malignant hyperthermia genetic susceptibility
  • CYP2C9 *5/*6 poor metaboliser
  • Protein-bound iodine below reference range
  • DNA injury
  • Amniotic fluid abnormal
  • Mitochondrial 1555 A to G mutation detected
  • Cytochrome P450 family 2 subfamily C member 9 *3/*3 poor metabolizer
  • Decreased molecular dissociation
  • Cortical blindness
  • Decreased lactose
  • Suppressor mutation
  • Constitutional mismatch repair deficiency syndrome due to PMS2 deficiency
  • Small deletion
  • Gene re-arrangement, B lymphocyte
  • Sample hemolyzed
  • Fibrinogen below reference range
  • Urobilin above reference range
  • Quantity of liquor
  • Sample slightly lipaemic
  • Abnormal carbohydrate sequence
  • Synovial fluid turbid
  • Inequality in circumference
  • Genetic susceptibility to genetic disorder
  • Pentose below reference range
  • Gene re-arrangement, T lymphocyte
  • Autosomal dominant combined variable immunodeficiency due to nuclear factor kappa B subunit 1 mutation
  • Decreased vitamin C
  • Porphyrin below reference range
  • Decreased size
  • Finding of amniotic fluid alpha-fetoprotein
  • Specimen lipemic
  • Glycogen above reference range
  • CYP4F2 poor metaboliser
  • Increased urobilin
  • Increased vitamin K
  • Vitamin B12 above reference range
  • Synovial fluid viscosity low
  • Decreased glycogen
  • Abnormal bone marrow iron
  • Multiple marker screen positive for increased nuchal translucency
  • CYP1A2 (cytochrome P450 family 1 subfamily A member 2) poor metabolizer
  • Specific gravity
  • Uric acid level below reference range
  • Cytochrome P450 family 3 subfamily A member 4 ultra-rapid metabolizer
  • Granulopenia
  • Increased ascorbic acid
  • Homogentisic acid above reference range
  • Autosomal recessive common variable immunodeficiency due to POU2AF1 mutation
  • Abnormal presence of galactose
  • Translucency finding
  • CYP2C9 rapid metaboliser
  • Cytochrome P450 family 2 subfamily C member 9 *6/*8 poor metabolizer
  • Amniotic fluid AFP
  • High risk human papillomavirus deoxyribonucleic acid test positive
  • Calculus = phosphate
  • Cytochrome P450 family 3 subfamily A member 4 rapid metabolizer
  • Xanthine below reference range
  • Abnormal amniotic fluid
  • Decrease in circumference
  • Decreased translucency
  • Lynch syndrome gene mutation detected
  • Amniotic fluid alpha-fetoprotein above reference range
  • Finding of contact sensitivity response
  • Frame-shift mutation
  • Finding of synovial fluid viscosity
  • Cytochrome P450 family 1 subfamily A member 2 poor metaboliser
  • CYP1A2 poor metaboliser
  • Increased amino acid
  • Mitotic alteration
  • Specimen haemolysed
  • CYP1A2 (cytochrome P450 family 1 subfamily A member 2) ultra-rapid metabolizer
  • Sample slightly icteric
  • Decreased bilirubin level
  • CYP1A2 ultra-rapid metaboliser
  • CYP2C9 *6/*11 poor metaboliser
  • Abnormal structure of physiologic substance
  • Increased molecular dissociation
  • Histidine above reference range
  • Uncertain malignant hyperthermia predisposition due to RyR1 gene mutation
  • Autosomal recessive CVID (common variable immunodeficiency) due to CD21 deficiency
  • Globulin below reference range
  • High risk variant of apolipoprotein L1 gene detected
  • Vitamin K epoxide reductase complex 1 ultra-rapid metaboliser
  • CK-19 (cytokeratin-19) fragment above reference range
  • Macromolecular cleavage
  • Cell chromosome examination abnormal
  • Multiple marker screen positive for Down syndrome
  • Cystine above reference range
  • Calculus = carbaptite
  • Cytochrome P450 family 2 subfamily C member 9 poor metaboliser
  • Cytochrome P450 family 2 subfamily C member 9 *5/*6 poor metaboliser
  • Molecular degradation
  • Gene re-arrangement
  • Specimen grossly lipemic
  • Cytochrome P450 family 3 subfamily A member 4 poor metabolizer
  • Gene amplification
  • Synovial fluid cloudy
  • Vanillylmandelic acid level below reference range
  • Beta amino isobutyric acid above reference range
  • Decreased vanillylmandelic acid level
  • Amino acid above reference range
  • Cold agglutinins present
  • Methaemalbumin above reference range
  • Decreased tyrosine
  • Choline above reference range
  • Calculus chemical composition
  • Autosomal dominant CVID (combined variable immunodeficiency) due to IRF2BP2 deficiency
  • Heterozygous NFKB inhibitor alpha gene mutation detected
  • CYP3A4 ultra-rapid metabolizer
  • Synovial fluid: uric acid
  • Amniotic fluid alpha-fetoprotein outside reference range
  • Increased adenylic acid
  • Decreased carbohydrate
  • Finding of synovial fluid composition
  • Cytochrome P450 family 4 subfamily F member 2 poor metabolizer
  • Synovial fluid viscosity high
  • Autosomal recessive combined variable immunodeficiency due to Rho guanine nucleotide exchange factor 1 mutation
  • Autosomal dominant combined variable immunodeficiency due to SEC61A1 deficiency
  • CYP2C9 rapid metabolizer
  • CYFRA 21-1 above reference range
  • Finding of oxygen saturation
  • Cytochrome P450 family 1 subfamily A member 2 ultra-rapid metaboliser
  • Uncertain genetic susceptibility to malignant hyperthermia due to ryanodine receptor 1 gene mutation
  • Contact sensitivity response - finding
  • Methemalbumin above reference range
  • Increased cystine
  • Promoter mutation
  • Triplication of alpha globin gene
  • Monocyte count outside reference range
  • Low risk variant of APOL1 (apolipoprotein L1) gene detected
  • Vitamin B12 level
  • Autosomal recessive combined immunodeficiency due to mannosidase alpha class 2B member 2 mutation
  • Cytochrome P450 family 2 subfamily C member 9 rapid metaboliser
  • CYP2C9 *6/*8 poor metabolizer
  • Progressive microcephaly, seizures, cortical blindness, developmental delay with combined immunodeficiency due to DIAPH1 deficiency
  • Satisfactory for evaluation but limited by partially obscuring air drying artifact
  • Increased pentose
  • High risk human papillomavirus detected
  • Specimen slightly hemolyzed
  • Autosomal recessive common variable immunodeficiency due to CD20 deficiency
  • Autosomal dominant combined immunodeficiency due to signal transducer and activator of transcription 5B mutation
  • Decreased urobilin
  • Glycogen below reference range
  • Abnormal quantity of physiologic substance
  • CYP2D6 (cytochrome P450 family 2 subfamily D member 6) rapid metaboliser
  • Increased cell mitotic activity
  • Sample lipemic
  • Gene re-arrangement, B lymphocyte, light chain
  • Cystine below reference range
  • Thyroid hormone level below reference range
  • Autosomal recessive combined immunodeficiency due to BCL10 mutation
  • Abnormal structure of cerebroside
  • Autosomal recessive combined immunodeficiency due to MAN2B2 deficiency
  • Inv22 - intron 22 inversion
  • Missense mutation
  • Gene re-arrangement, gamma chain, T cell antigen receptor
  • Allelic exclusion
  • Multiple marker screen positive for trisomy 18
  • Autosomal recessive combined immunodeficiency due to REL proto-oncogene NF-kappa-B subunit mutation
  • Increased homogentisic acid
  • Autosomal recessive common variable immunodeficiency due to CD20 mutation
  • Specific gravity - finding
  • Sample grossly icteric
  • CYP2C9 *6/*6 poor metabolizer
  • Structural variant
  • Influenza A H1N1 virus 2009 pandemic strain present
  • GU test finding
  • Autosomal dominant combined variable immunodeficiency due to IRF2BP2 mutation
  • Increased histidine
  • Ketone bodies above reference range
  • Constitutional mismatch repair deficiency syndrome
  • Decreased protein-bound iodine
  • Urobilinogen level below reference range
  • NAT2 (N-acetyltransferase 2) slow acetylator
  • Folic acid above reference range
  • Autosomal recessive combined immunodeficiency due to REL mutation
  • Satisfactory for evaluation but limited by partially obscuring thick areas
  • Autosomal recessive common variable immunodeficiency due to CD21 mutation
  • Heterozygous protocadherin 19 gene mutation positive
  • VKORC1 poor metaboliser
  • Vesicular reaction
  • Phosphate calculus of kidney
  • Cytochrome P450 family 2 subfamily C member 19 rapid metaboliser
  • Heterozygous nuclear factor of kappa light polypeptide gene enhancer In B-cells inhibitor, alpha gene mutation positive
  • High risk HPV (human papillomavirus) DNA (deoxyribonucleic acid) detected
  • Phosphatase and tensin homolog gene mutation detected
  • UTR (untranslated region) mutation
  • Autosomal recessive combined immunodeficiency due to component of inhibitor of nuclear factor kappa B kinase complex mutation
  • CYP1A2 ultra-rapid metabolizer
  • Cytochrome P450 family 2 subfamily C member 9 ultra-rapid metabolizer
  • N-acetyltransferase 2 slow acetylator
  • Specimen involvement by multifocal invasion
  • Karyotype evaluation abnormal
  • VKORC1 ultra-rapid metaboliser
  • Autosomal recessive combined immunodeficiency due to ITPKB mutation
  • Decreased fibrinogen
  • Depolymerization
  • Finding of presence of crystals
  • Increased methaemalbumin
  • Increased vanillylmandelic acid level
  • Increased vitamin A
  • Macromolecular nicking
  • Mutation of promoter
  • Sample grossly hemolyzed
  • Macromolecular binding
  • Autosomal recessive combined variable immunodeficiency due to PIK3CG deficiency
  • Decreased uroporphyrin
  • Finding of amniotic fluid volume
  • Autosomal dominant combined variable immunodeficiency due to interferon regulatory factor 2 binding protein 2 mutation
  • Synovial fluid: pyrophosphate
  • CYP3A5 (cytochrome P450 family 3 subfamily A member 5) ultra-rapid metabolizer
  • Protein electrophoresis outside reference range
  • CYP3A4 (cytochrome P450 family 3 subfamily A member 4) ultra-rapid metaboliser
  • Decreased cystine
  • Sample grossly lipemic
  • Abnormal macromolecular sequence
  • CMMR-D (constitutional mismatch repair deficiency) syndrome
  • Orotic acid above reference range
  • Autosomal recessive CVID (common variable immunodeficiency) due to CD20 deficiency
  • Vitamin K epoxide reductase complex 1 poor metaboliser
  • Shrinkage
  • Effect of antioestrogen agent
  • Amniotic fluid AFP (alpha-fetoprotein) abnormal
  • Mutation of untranslated region
  • VKORC1 (vitamin K epoxide reductase complex 1) poor metabolizer
  • Specimen lipaemic
  • Fructose below reference range
  • Mannoheptulose below reference range
  • Mitochondrial 1555 A to G mutation positive
  • Lactose above reference range
  • Cytochrome P450 family 2 subfamily C member 9 *2/*3 poor metabolizer
  • Folic acid below reference range
  • Heterozygous NFKBIA gene mutation positive
  • Nonsense mutation
  • Alpha-fetoprotein above reference range
  • Carbohydrate below reference range
  • Oxygen saturation above reference range
  • Autosomal dominant combined immunodeficiency due to STAT5b mutation
  • Molecular conformation
  • Multiple marker screening test positive for Down syndrome
  • CYP3A4 rapid metabolizer
  • Synovial fluid bloodstained
  • Autosomal recessive combined immunodeficiency due to BCL10 deficiency
  • Calculus = triple phosphate
  • Cytochrome P450 family 2 subfamily C member 9 *6/*11 poor metabolizer
  • CYP2D6 rapid metabolizer
  • Progressive microcephaly, seizures, cortical blindness, developmental delay syndrome
  • Orotic acid below reference range
  • Fructose above reference range
  • Joint fluid hemorrhagic
  • Positive genetic finding
  • CYP2C9 (cytochrome P450 family 2 subfamily C member 9) rapid metabolizer
  • Abnormal presence of myoglobin
  • Tyrosine above reference range
  • Finding of bone marrow erythropoiesis
  • Positive for tumor protein p53
  • CYP3A5 ultra-rapid metabolizer
  • Autosomal recessive combined variable immunodeficiency due to phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma mutation
  • CYP1A2 rapid metabolizer
  • Autosomal recessive common variable immunodeficiency due to BOB1 deficiency
  • CYP2C9 *6/*6 poor metaboliser
  • VKORC1 rapid metabolizer
  • Cytochrome P450 family 2 subfamily C member 9 poor metabolizer
  • Increased mannoheptulose
  • Molecular instability
  • Conformational change
  • Decreased beta amino isobutyric acid
  • ATP binding cassette subfamily G member 2 decreased function
  • Autosomal dominant CVID (combined variable immunodeficiency) due to TNFSF12 mutation
  • NAT 2 (N-acetyltransferase 2) poor metaboliser
  • Phosphate kidney stone
  • Methemalbumin below reference range
  • Specimen slightly lipemic
  • Vitamin K epoxide reductase complex 1 rapid metabolizer
  • CYP1A2 rapid metaboliser
  • Denaturation
  • High risk HPV (human papillomavirus) test positive
  • Sample lipaemic
  • Influenza A virus subtype H1 present
  • Addition-deletion mutation
  • CYP2C9 poor metaboliser
  • Cytochrome P450 family 2 subfamily C member 19 rapid metabolizer
  • Triplicated alpha globin gene
  • Ascorbic acid above reference range
  • Specimen slightly haemolysed
  • CYP2D6 rapid metaboliser
  • Intron 1 inversion
  • Beta amino isobutyric acid below reference range
  • Cytochrome P450 family 2 subfamily C member 9 *2/*3 poor metaboliser
  • Autosomal recessive combined immunodeficiency due to c-Rel deficiency
  • Decreased adenosine monophosphate
  • Foetal tissue present in specimen
  • Decreased histidine
  • Autosomal recessive combined variable immunodeficiency due to BAFF receptor deficiency
  • Galactose above reference range
  • Cytokeratin 19 fragment above reference range
  • Progressive microcephaly, seizures, cortical blindness, developmental delay with combined immunodeficiency due to DIAPH1 mutation
  • Breast cancer genetic marker of susceptibility positive
  • Abnormal presence of pentose
  • CYP2C9 (cytochrome P450 family 2 subfamily C member 9) ultra-rapid metaboliser
  • CYP4F2 (cytochrome P450 family 4 subfamily F member 2) poor metabolizer
  • Finding of presence of ova cysts and parasites
  • VKORC1 (vitamin K epoxide reductase complex 1) ultra-rapid metaboliser
  • Cytochrome P450 family 2 subfamily C member 9 *6/*6 poor metabolizer
  • Cytochrome P450 family 2 subfamily D member 6 rapid metabolizer
  • Human papillomavirus deoxyribonucleic acid test positive
  • Increased ceroid
  • Synovial fluid: fibrin clot +
  • Joint fluid haemorrhagic
  • High cancer antigen 27-29 level
  • Autosomal dominant CVID (combined variable immunodeficiency) due to NFKB1 deficiency
  • Abnormal presence of haemoglobin
  • Measurement finding below reference range
  • Autosomal recessive combined immunodeficiency due to IKK-alpha deficiency
  • Rarefaction
  • Abnormally soft consistency
  • Presence of crystals - finding
  • Down syndrome detected by multiple marker screening
  • Adenylic acid above reference range
  • Unstable molecule
  • Tumour protein p53 detected
  • Increase in circumference
  • VKORC1 (vitamin K epoxide reductase complex 1) ultra-rapid metabolizer
  • Abnormal thickness
  • Lactose below reference range
  • Decreased globulin
  • Autosomal dominant combined variable immunodeficiency due to SEC61 translocon subunit alpha 1 mutation
  • Decreased cell mitotic activity
  • Decreased pentose
  • Autosomal dominant combined variable immunodeficiency due to TWEAK deficiency
  • CYP2C19 rapid metaboliser
  • CYP3A4 ultra-rapid metaboliser
  • Cytochrome P450 family 1 subfamily A member 2 rapid metaboliser
  • Stringing of synovial fluid
  • Finding of monocyte count
  • Macromolecular alteration
  • Cytochrome P450 family 3 subfamily A member 5 ultra-rapid metabolizer
  • Bone marrow normoblastic
  • Autosomal recessive combined variable immunodeficiency due to B cell-activating factor receptor mutation
  • Increased orotic acid
  • Vitamin E above reference range
  • Combined immunodeficiency due to IKZF2 mutation
  • Autosomal recessive common variable immunodeficiency due to CD21 deficiency
  • Increased carbohydrate
  • Increased adenosine monophosphate
  • Fetal tissue present in specimen
  • Joint fluid bloody
  • VKORC1 rapid metaboliser
  • Synovial fluid composition - finding
  • Vitamin K epoxide reductase complex 1 poor metabolizer
  • Autosomal recessive common variable immunodeficiency due to MS4A1 mutation
  • Blood in synovial fluid
  • K19 (keratin-19) fragment above reference range
  • Cholesterol/high density lipoprotein ratio above reference range
  • Lactic acid level above reference range
  • Increased beta amino isobutyric acid
  • Sample slightly lipemic
  • Autosomal recessive combined variable immunodeficiency due to BAFF-R deficiency
  • Autosomal recessive common variable immunodeficiency due to POU class 2 homeobox associating factor 1 mutation
  • Specimen icteric
  • Vitamin A above reference range
  • Abnormal molecular cross-linking
  • Tissue specimen fragmented
  • Cytochrome P450 family 2 subfamily D member 6 rapid metaboliser
  • Measurement finding above reference range
  • Genetic susceptibility to malignant hyperthermia due to calcium voltage-gated channel subunit alpha1 S gene mutation positive
  • Decreased xanthine
  • Synonymous single nucleotide substitution
  • Finding of oligohydramnios
  • Progressive microcephaly, seizures, cortical blindness, developmental delay syndrome with combined immunodeficiency due to diaphanous related formin 1 mutation
  • Decreased urobilinogen level
  • High-risk HPV (human papillomavirus) DNA test positive
  • Cytochrome P450 family 3 subfamily A member 4 rapid metaboliser
  • Decreased choline
  • Synovial fluid yellow
  • Decreased ascorbic acid
  • Abnormal amino acid sequence
  • Cytochrome P450 family 3 subfamily A member 4 poor metaboliser
  • Foetal anomaly present in specimen
  • Increased vitamin D
  • Extra chromosomal inheritance
  • CYP2C9 *5/*6 poor metabolizer
  • Finding related to physiologic substance
  • Choline below reference range
  • Autosomal dominant CVID (combined variable immunodeficiency) due to SEC61A1 deficiency
  • Decreased thyroid hormone level
  • Depolymerisation
  • Specimen slightly lipaemic
  • Positive for tumour protein p53
  • Bone marrow iron finding
  • ATP binding cassette subfamily G member 2 poor function
  • Abnormal structure of phospholipid
  • Decreased methaemalbumin
  • Genetic susceptibility to malignant hyperthermia due to calcium voltage-gated channel subunit alpha1 S gene mutation
  • CYP3A4 (cytochrome P450 family 3 subfamily A member 4) ultra-rapid metabolizer
  • Superhelicity
  • Cytochrome P450 family 2 subfamily C member 9 *5/*6 poor metabolizer
  • Mutation of p53 gene
  • Abnormally increased laxness
  • Laxity
  • CYP3A4 poor metaboliser
  • Cytochrome P450 family 3 subfamily A member 4 ultra-rapid metaboliser
  • Decreased mannoheptulose
  • CYP3A4 (cytochrome P450 family 3 subfamily A member 4) rapid metabolizer
  • Somatic mutation
  • Genetic susceptibility to malignant hyperthermia
  • Mutation of p53 gene present
  • Genetic variation
  • Autosomal recessive combined immunodeficiency due to CHUK mutation
  • BRAF serine threonine kinase gene mutation detected
  • Temperature-sensitive mutation
  • Increased folic acid
  • VKORC1 poor metabolizer
  • Autosomal recessive combined immunodeficiency due to ITPKB deficiency
  • Decreased folic acid
  • Sample grossly lipaemic
  • CYP2D6 (cytochrome P450 family 2 subfamily D member 6) rapid metabolizer
  • Calculus = cholesterol
  • VKORC1 (vitamin K epoxide reductase complex 1) rapid metaboliser
  • Specimen too thick for optimal interpretation
  • Specimen grossly hemolyzed
  • Genitourinary test finding
  • Point mutation
  • Absent bone marrow iron
  • Glucose level above reference range
  • HPV (human papillomavirus) DNA (deoxyribonucleic acid) test positive
  • Cytochrome P450 family 1 subfamily A member 2 ultra-rapid metabolizer
  • Cytochrome P450 family 2 subfamily C member 9 *6/*11 poor metaboliser
  • Decreased fructose
  • Increased laxness
  • Autosomal dominant combined variable immunodeficiency due to IRF2BP2 deficiency
  • Decreased macromolecular binding
  • Genetic linkage equilibrium
  • Gene re-arrangement, alpha chain, T cell antigen receptor
  • CYP1A2 (cytochrome P450 family 1 subfamily A member 2) rapid metaboliser
  • Abnormal consistency
  • Decreased uric acid level
  • Increased urobilinogen level
  • Vitamin K epoxide reductase complex 1 rapid metaboliser
  • Alpha-fetoprotein raised
  • Gene re-arrangement, beta chain, T cell antigen receptor
  • Triple screening test positive for Down syndrome
  • Effect of antiestrogen agent
  • Amount of liquor
  • Monocyte count abnormal
  • Finding of synovial fluid appearance
  • Mitochondrial mutation
  • Diminution of size
  • Sample slightly haemolysed
  • Retraction
  • Aceto-white reaction finding
  • Meiotic alteration
  • High risk variant of APOL1 (apolipoprotein L1) gene detected
  • Finding of calculus chemical composition
  • Increased vitamin B12
  • Sample grossly haemolysed
  • Urobilinogen level above reference range
  • Finding of bilirubin level
  • High risk human papillomavirus deoxyribonucleic acid detected
  • Autosomal recessive common variable immunodeficiency due to CR2 mutation
  • CYP2C19 rapid metabolizer
  • Keratin, type I cytoskeletal 19 fragment above reference range
  • Autosomal recessive CVID (combined variable immunodeficiency) due to PIK3CG deficiency
  • Cytochrome P450 family 2 subfamily C member 9 ultra-rapid metaboliser
  • Genetic inversion
  • Autosomal dominant combined variable immunodeficiency due to tumour necrosis factor-like weak inducer of apoptosis mutation
  • Autosomal dominant combined variable immunodeficiency due to NFKB1 mutation
  • Autosomal dominant combined variable immunodeficiency due to tumor necrosis factor-like weak inducer of apoptosis mutation
  • Abnormal translucency
  • Defective molecular assembly
  • Human epidermal growth factor receptor 2 gene amplification detected
  • Low risk variant of apolipoprotein L1 gene detected
  • Decreased vitamin B
  • Abnormally decreased organ weight
  • CYP1A2 (cytochrome P450 family 1 subfamily A member 2) rapid metabolizer
  • Elevated cholesterol/high density lipoprotein ratio
  • CYP3A4 poor metabolizer
  • Strand breaks
  • Decreased adenylic acid
  • Increased tyrosine
  • Increased lactose
  • Sample slightly hemolyzed
  • Satisfactory for evaluation but limited by partially obscuring air drying artefact
  • Increased biliverdin
  • Increased vitamin E
  • Finding of quantity of liquor
  • Increased vitamin C
  • Positive skin test reaction
  • PTEN (phosphatase and tensin homolog) gene mutation detected
  • Splice site mutation
  • Monocyte count
  • Finding of organ weight
  • Bilirubin level - finding
  • CYP1A2 (cytochrome P450 family 1 subfamily A member 2) ultra-rapid metaboliser
  • Vitamin K above reference range
  • Cytochrome P450 family 2 subfamily C member 9 rapid metabolizer
  • Aceto-white reaction positive
  • Synovial fluid fibrin clot
  • Gene re-arrangement, B lymphocyte, heavy chain
  • Liquor volume below reference range
  • CYP4F2 poor metabolizer
  • Autosomal recessive CVID (combined variable immunodeficiency) due to ARHGEF1 deficiency
  • Increased diameter
  • Amniotic fluid volume below reference range
  • Quantity of physiologic substance outside reference range
  • Vanillylmandelic acid level above reference range
  • CYP2C9 *2/*3 poor metabolizer
  • Xanthine above reference range
  • High risk human papillomavirus positive
  • AFP - Alpha-fetoprotein raised
  • Autosomal recessive combined variable immunodeficiency due to ARHGEF1 mutation
  • Joint fluid cloudy
  • Nucleotide base deletion
  • Sample haemolysed
  • Bilirubin level below reference range
  • Bilirubin level
  • Smear too thick for optimal interpretation
  • Cold agglutinins detected
  • Fetal anomaly present in specimen
  • Sample icteric
  • CYP2C9 *6/*8 poor metaboliser
  • Increased choline
  • Granulocyte count below reference range
  • Increased nuchal translucency detected by multiple marker screening
  • Presence of ova cysts and parasites - finding
  • Reading-frame-shift mutation
  • Autosomal recessive combined immunodeficiency due to BCL10 immune signaling adaptor mutation
  • Autosomal recessive combined immunodeficiency due to inositol-trisphosphate 3-kinase B mutation
  • CYP2C9 (cytochrome P450 family 2 subfamily C member 9) rapid metaboliser
  • Specimen grossly haemolysed
  • Tissue specimen ruptured
  • Cytochrome P450 family 2 subfamily C member 9 *6/*6 poor metaboliser
  • Fragmented tissue specimen
  • CYP3A4 (cytochrome P450 family 3 subfamily A member 4) rapid metaboliser
Frequently Asked Questions
What is the ICD-10 code for oth abnormal findings in specimens from oth org/tiss?

The ICD-10-CM code for oth abnormal findings in specimens from oth org/tiss is R89.8. The full clinical description is "Other abnormal findings in specimens from other organs, systems and tissues". R89.8 is a billable/specific code that can be used on insurance claims and medical billing.

What does ICD-10 code R89.8 mean?

ICD-10-CM code R89.8 represents “Other abnormal findings in specimens from other organs, systems and tissues”. It is classified under Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings and is a billable/specific code that can be used on a claim.

Is R89.8 a billable code?

Yes, R89.8 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is R89.8 in?

R89.8 is in Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings (codes R00-R99).

What codes cannot be used with R89.8?

R89.8 has Excludes1 notes indicating codes that cannot be used together with it, including: abnormal findings on antenatal screening of mother (O28.-); diagnostic abnormal findings classified elsewhere - see Alphabetical Index.

What SNOMED CT codes does R89.8 map to?

R89.8 maps to 331 SNOMED CT concepts: 1351233008, 1351232003, 166561008, 69604007, 42170009, and 326 more. SNOMED CT is a clinical terminology used in electronic health records.

What are the UMLS CUIs for R89.8?

R89.8 is linked to 2 UMLS Concept Unique Identifiers: C2830575, C0478185. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

How does R89.8 relate to ICF functioning codes?

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like oth abnormal findings in specimens from oth org/tiss affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

What is the ICD-11 equivalent of R89.8?

R89.8 maps to the ICD-11 code: MG6Y (Other specified clinical findings in specimens from other specified organs, systems and tissues).

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.